MedPath

Short Term Results of Tele-Rehabilitation

Not Applicable
Completed
Conditions
COVID-19
Dyspnea
Interventions
Other: Tele-rehabillitation
Other: Prescribed Exercise Program
Registration Number
NCT05381675
Lead Sponsor
Harran University
Brief Summary

Most people who have coronavirus disease (COVID-19) recover completely without any sequelae. However, some patients continue to experience symptoms of COVID-19 even though their tests turn negative. This clinical spectrum that occurs after acute infection is called the post-COVID syndrome (PCS). Dyspnea, pain, decreased exercise capacity, limitations in activities of daily living, poor sleep quality, anxiety and depression are common symptoms in PCS. The aim of our study is to examine the effect of tele-rehabilitation-based exercise program on dyspnea, pain, functional capacity, sleep quality, anxiety and depression in individuals with PCS.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Being between the ages of 18-75,
  • Being in stable medical condition, conscious and cooperative,
  • Having had COVID and continuing symptoms
  • Volunteering to participate in the study,
  • Own a device that can be connected online independently or with support from family members.
Exclusion Criteria

SpO2 < 92%,

  • Hypotension (Systolic Blood Pressure < 90 mmHg or Diastolic Blood Pressure < 60mmHg)
  • Having chronic respiratory disease (COPD, Asthma, etc.)
  • Having a stroke or neurodegenerative disease.
  • Not being willing to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionTele-rehabillitationParticipants will receive a supervised tele-rehabilitation program 2 days a week for 6 weeks.
ControlPrescribed Exercise ProgramParticipants will receive the same rehabilitation program as prescribed.
Primary Outcome Measures
NameTimeMethod
Change from the baseline to the 6th week in mMRC (Modified Medical Research Council) Dyspnoea ScaleBaseline and 6th week

The mMRC Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea

Secondary Outcome Measures
NameTimeMethod
Change from the baseline to the 6th week in the 5 times sit to stand test (5XSST)Baseline and 6th week

The 5XSST scoring is based on the amount of time (to the nearest decimal in seconds) a patient is able to transfer from a seated to a standing position and back to sitting five times. The equipment need in performing 5XSST test includes: Stopwatch and standard height chair with straight back.

Change from the baseline to the 6th week in the The Pittsburgh Sleep Quality IndexBaseline and 6th week

The Pittsburgh Sleep Quality Index (PSQI) is a measure of self-reported sleep quality and sleep disturbance. Scoring Using a four-point, Likert-type scale, respondents indicate how frequently they exhibit certain sleep behaviors (0 = "few," 1 = "some- times," 2 = "often," and 3 = "almost always"). The PSQI takes about 10 minutes to complete and it doesn't involve any procedures or interventions.

Change from the baseline to the 6th week in NPRSBaseline and 6th week

The Numerical Rating Scale (NPRS-11) is an 11-point scale for self-report of pain. It is the most commonly used unidimensional pain scale. The respondent selects a whole number (integers 0-10) that best reflects the intensity (or other quality if requested of his/her pain.

Change from the baseline to the 6th week in the Hospital Anxiety and Depression ScaleBaseline and 6th week

The Hospital Anxiety and Depression Scale (HADS) was devised to measure anxiety and depression in a general medical population of patients. The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately.

Trial Locations

Locations (1)

İstanbul University-Cerrahpasa

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath